Roche Pharma, a global leader in biotechnology and pharmaceuticals, has announced a monumental investment of 1.5 billion Swiss francs (approximately Rs. 14,000 crore) in India. This marks one of the largest foreign direct investments in the country’s healthcare sector. The capital will be channeled toward expanding clinical research, strengthening manufacturing capabilities, and enhancing access to advanced therapies.